[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE209208T1 - Zwischenprodukte und verfahren zur herstellung olanzapin - Google Patents

Zwischenprodukte und verfahren zur herstellung olanzapin

Info

Publication number
ATE209208T1
ATE209208T1 AT97307383T AT97307383T ATE209208T1 AT E209208 T1 ATE209208 T1 AT E209208T1 AT 97307383 T AT97307383 T AT 97307383T AT 97307383 T AT97307383 T AT 97307383T AT E209208 T1 ATE209208 T1 AT E209208T1
Authority
AT
Austria
Prior art keywords
olnzapine
producing
intermediate products
products
producing olnzapine
Prior art date
Application number
AT97307383T
Other languages
English (en)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE209208(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE209208T1 publication Critical patent/ATE209208T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97307383T 1996-09-23 1997-09-22 Zwischenprodukte und verfahren zur herstellung olanzapin ATE209208T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
ATE209208T1 true ATE209208T1 (de) 2001-12-15

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97307383T ATE209208T1 (de) 1996-09-23 1997-09-22 Zwischenprodukte und verfahren zur herstellung olanzapin

Country Status (36)

Country Link
US (1) US6020487A (de)
EP (1) EP0831098B1 (de)
JP (2) JP2001500877A (de)
KR (1) KR100560015B1 (de)
CN (1) CN1122036C (de)
AR (1) AR013838A1 (de)
AT (1) ATE209208T1 (de)
AU (1) AU719441B2 (de)
BR (1) BR9712100A (de)
CA (1) CA2265712C (de)
CO (1) CO4910140A1 (de)
CZ (1) CZ299248B6 (de)
DE (1) DE69708428T2 (de)
DK (1) DK0831098T3 (de)
EA (1) EA001642B1 (de)
EG (1) EG23861A (de)
ES (1) ES2166051T3 (de)
HK (1) HK1009807A1 (de)
HU (1) HU226484B1 (de)
ID (1) ID27275A (de)
IL (1) IL128962A (de)
IN (1) IN187156B (de)
MY (1) MY125565A (de)
NO (1) NO323980B1 (de)
NZ (1) NZ334448A (de)
PE (1) PE110398A1 (de)
PL (3) PL196068B1 (de)
PT (1) PT831098E (de)
RS (1) RS49598B (de)
SI (1) SI0831098T1 (de)
SV (1) SV1997000081A (de)
TR (1) TR199900640T2 (de)
TW (1) TW470746B (de)
UA (1) UA59371C2 (de)
WO (1) WO1998012199A1 (de)
ZA (1) ZA978515B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
EP1440074A1 (de) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Olanzapin dihydrat-ii, verfahren zu ihrer herstellung und ihre anwendung
US6906062B2 (en) 2001-12-24 2005-06-14 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-menthyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
US7297789B2 (en) * 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
EP1575962A1 (de) 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Neue kristallformen von olanzapin, verfahren zu deren herstellung und verfahren zur herstellung bekannter kristallformen von olanzapin
CA2546200A1 (en) * 2003-11-18 2005-06-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
DE602005027308D1 (de) 2004-01-27 2011-05-19 Synthon Bv Stabile salze von olanzapin
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
EA200701065A1 (ru) * 2004-11-16 2007-12-28 Элан Фарма Интернэшнл Лтд. Инъецируемые составы, содержащие нанодисперсный оланзапин
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (de) 2011-02-14 2012-08-15 Labtec GmbH Orale Filmformulierungen für Olanzapin mit schneller Zersetzung
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンii型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
ATE198891T1 (de) * 1992-05-29 2001-02-15 Lilly Co Eli Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
JP2001500878A (ja) * 1996-09-23 2001-01-23 イーライ・リリー・アンド・カンパニー オランザピン二水和物d

Also Published As

Publication number Publication date
SI0831098T1 (en) 2002-04-30
DE69708428T2 (de) 2002-07-04
MY125565A (en) 2006-08-30
PL196069B1 (pl) 2007-12-31
AR013838A1 (es) 2001-01-31
UA59371C2 (uk) 2003-09-15
NO323980B1 (no) 2007-07-30
YU15599A (sh) 2001-12-26
IN187156B (de) 2002-02-16
DK0831098T3 (da) 2002-05-21
US6020487A (en) 2000-02-01
CN1234802A (zh) 1999-11-10
EG23861A (en) 2007-11-18
HK1009807A1 (en) 1999-06-11
EA001642B1 (ru) 2001-06-25
IL128962A0 (en) 2000-02-17
ID27275A (id) 2001-03-22
HUP0000066A3 (en) 2000-11-28
ES2166051T3 (es) 2002-04-01
IL128962A (en) 2003-01-12
EP0831098A3 (de) 1998-04-29
TR199900640T2 (xx) 1999-06-21
CZ99099A3 (cs) 1999-11-17
CZ299248B6 (cs) 2008-05-28
KR20000048520A (ko) 2000-07-25
NO991382D0 (no) 1999-03-22
CN1122036C (zh) 2003-09-24
DE69708428D1 (de) 2002-01-03
CA2265712C (en) 2006-10-31
KR100560015B1 (ko) 2006-03-15
BR9712100A (pt) 1999-08-31
AU4484197A (en) 1998-04-14
SV1997000081A (es) 1999-01-14
EA199900326A1 (ru) 1999-08-26
PL196068B1 (pl) 2007-12-31
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
TW470746B (en) 2002-01-01
PE110398A1 (es) 1999-01-14
PL332482A1 (en) 1999-09-13
HUP0000066A2 (hu) 2000-06-28
HU226484B1 (en) 2009-03-02
RS49598B (sr) 2007-06-04
CO4910140A1 (es) 2000-04-24
JP2001500877A (ja) 2001-01-23
NO991382L (no) 1999-03-22
PL194565B1 (pl) 2007-06-29
CA2265712A1 (en) 1998-03-26
AU719441B2 (en) 2000-05-11
PT831098E (pt) 2002-04-29
EP0831098A2 (de) 1998-03-25
JP2009242407A (ja) 2009-10-22
ZA978515B (en) 1999-03-23
EP0831098B1 (de) 2001-11-21

Similar Documents

Publication Publication Date Title
DE69716779D1 (de) Produkte und verfahren zur herstellung von dilatatoren
DE69429873D1 (de) Teilchenförmige aromazusammenstellungen und verfahren zur herstellung derselben
DE69527054D1 (de) Retroreflektierender gegenstand und verfahren zur herstellung
ATE258180T1 (de) Verfahren zur herstellung von glufosinate und zwischenprodukte dafür
DE69626833D1 (de) Ernährungsergänzungsgetränk und verfahren zur herstellung desselben
ATE283847T1 (de) Verfahren zur herstellung von zwischenprodukten des florfenicols
DE69530954D1 (de) Mikromechanisches Bauelement und Verfahren zur Herstellung desselben
DE69829181D1 (de) Verbesserte trennsäulen und verfahren zur herstellung der verbesserten trennsäulen
DE69508529D1 (de) Verfahren und Vorrichtung zur Herstellung von lufthaltigen gefrorenen Produkten
DE69706429D1 (de) Verbesserte metalbehalter und verfahren zur herstellung
ATE209208T1 (de) Zwischenprodukte und verfahren zur herstellung olanzapin
DE69522324D1 (de) Farblampe und verfahren zur herstellung derselben
DE59707163D1 (de) Giessanlage und verfahren zur herstellung von gussstücken
DE69813312D1 (de) Verfahren zur herstellung von cyclopropylethyn sowie zwischenprodukte zur herstellung von cyclopropylethyn
DE69624792T2 (de) Verfahren und Vorrichtung zur Herstellung von lufthaltigen gefrorenen Produkten
DE69631943D1 (de) Substituierte camptothecinderivate und verfahren zur ihrer herstellung
DE69511248D1 (de) Polycarbomate, verfahren zur herstellung von polycarbomaten und verfahren zur herstellung von polyisocyanaten
DE69622051D1 (de) Verfahren zur herstellung von 2,4-dihydroxy-pyridin und 2,4-dihydroxy-3-nitropyridin
ATE249452T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE69613964D1 (de) Verfahren zur herstellung von pentafluoroethan und tetrafluorochloroethan
DE69522674D1 (de) Aluminiumnitrid sinterprodukt und verfahren zur herstellung desselben
DE69515697D1 (de) Blockcopolymere und verfahren zur herstellung
DE69706976D1 (de) Kontinuierliches verfahren zur herstellung von hydrocarbylaluminoxanen
DE69522561D1 (de) Verfahren zur herstellung von benzophentionen und benzophenonen
ATE214373T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification